Latest Breaking News On - Cellular therapy - Page 1 : vimarsana.com

Teclistamab Triplet Shows Manageable Safety, Early Efficacy in Transplant-Ineligible Myeloma

Teclistamab plus daratumumab and lenalidomide had a manageable safety profile in patients with transplant-ineligible, newly diagnosed multiple myeloma.

Data for Quadruplet Therapies Could Alter Frontline SOC for Transplant-Ineligible Multiple Myeloma

Muhamed Baljevic, MD, FACP, discusses the investigation of frontline quadruplet therapies in transplant-ineligible multiple myeloma.

First-Line Quadruplet Regimens Continue to Enhance Outcomes in Myeloma

Muhamed Baljevic, MD, FACP, discusses the evolution of quadruplet combination therapies in frontline multiple myeloma.

Vanderbilt Symposium Highlights Recent Data on Novel Agents Under Evaluation in Hematologic Malignancies

Dr Porter on Understanding Gaps in CAR T-Cell Therapy for R/R CLL

Dr Baljevic on Key Considerations for Treatment Selection in Newly Diagnosed Multiple Myeloma

Muhamed Baljevic, MD, discusses the consideration of patient comorbidities and preferences during treatment selection in newly diagnosed myeloma.

Despite enduring disparities, stem cell transplants expand across all races, ethnicities

The amount of autologous and allogeneic hematopoietic stem cell transplants for hematologic disorders has increased over time in tandem with longer survival, according to results of an observational study. Researchers observed improvements across all racial and ethnic groups but found that disparities related to treatment outcomes still exist.

CAR T-Cell Therapies Move Ahead in Pediatric and Adult ALL

Carrie L. Kitko, MD, discusses the current standing of cellular therapies in adult and pediatric ALL and looks toward future developments.

Navigating the Growing Landscape of JAK Inhibitors in Myelofibrosis

Ashwin Kishtagari, MD, discusses the treatment of patients with myelofibrosis following progression on ruxolitinib.

Dr Baljevic on Advancements in the Management of Newly Diagnosed Multiple Myeloma

Muhamed Baljevic, MD, discusses key trial updates and advancements with quadruplet therapy in newly diagnosed multiple myeloma.